A safety evaluation of evolocumab

Roth, EM

Roth, EM (reprint author), Univ Cincinnati, Div Cardiovasc Hlth & Dis, Cincinnati, OH 45220 USA.; Roth, EM (reprint author), Sterling Res Grp LTD, Cincinnati, OH 45246 USA.

EXPERT OPINION ON DRUG SAFETY, 2018; 17 (1): 99

Abstract

Introduction: Evolocumab is an injectable, fully human monoclonal antibody and a member of the newest class of low density lipoprotein cholesterol (LD......

Full Text Link